Association for Accessible Medicines

Home
United States
Washington D.C., DC
Association for Accessible Medicines

Association for Accessible Medicines promotes policies, including greater competition, to ensure mor

The Association for Accessible Medicines promotes policies, including greater competition, to ensure more generic and biosimilar medicines are more accessible to more people who need them.

01/02/2026

A decade after the first entered to the U.S. market, $56.2 billion have been saved by the healthcare system and 3.3 billion additional days of patient care have been possible. But due to harmful policies that impeded biosimilar uptake, we are currently experiencing a biosimilar void. Policymakers must ACT NOW to safeguard enormous benefits to Americans—$20.2 billion in 2024, alone. MORE: https://accessiblemeds.org/resources/blog/2025-savings-report

12/30/2025

Generic medicines give America's patients the confidence to thrive! Last year, comprised 90% of all prescriptions filled, but only 12% of prescription spending. In sharp contrast, brand drugs supported patients less often— making up only 10% of prescriptions filled but adding up to 88% of the total drug spend. Learn more about what makes generic medicines unique in AAM’s : https://accessiblemeds.org/resources/blog/2025-savings-report

12/29/2025

Join us at , February 23–25 in Miami, Florida! 🌴 AAM’s annual meeting brings together policymakers, influential speakers and industry leaders to discuss the future of and .

Discussions center around hot topics — including breakthroughs that shape the policy impacting our industry. It’s an opportunity to hear first-hand from world-renowned speakers and learn about where our industry is heading and what the future may hold.

Register today: https://access.accessiblemeds.org

12/26/2025

In 2024, & saved America’s patients and the U.S. healthcare system $467 billion—and $3.4 trillion in the past 10 years. Learn more, including what can be done to help safeguard this important industry: https://accessiblemeds.org/resources/blog/2025-savings-report

12/23/2025

From our AAM family to you and yours, please have a safe and happy holiday season! And remember to visit https://accessiblemeds.org to learn how a healthy and medicines industry will help America's patients THRIVE in 2026!

12/22/2025

Reserve your spot now and save before hotel rates increase.

brings together policymakers, industry leaders, and expert voices to discuss the landscape shaping generics and biosimilars. Here’s a snapshot of the sessions you won’t want to miss:
🔹 State of the Industry: A forward look at 2026 and beyond
🔹 Healthcare Innovation & the Political Landscape: Insights from a former commissioner
🔹 Policy Priorities from Washington, D.C.: What’s happening on Capitol Hill
🔹 Reid Strategic Conversation: The power of narrative in healthcare
🔹 Wall Street Perspectives: Market trends influencing medicines
🔹 Biosimilars Panel: Wins, challenges, and what’s needed next
🔹 Global & U.S. Trends: Cost savings, access, and pipeline outlook
🔹 CEOs Unplugged: Leadership perspectives on opportunity and change

Register now: https://access.accessiblemeds.org/

12/19/2025

Over the next decade, 118 biologics are expected to lose patent exclusivity, presenting a $234 billion opportunity for biosimilars in the U.S. But of these 118 biologics, only 12 molecules currently have biosimilars in development. Closing this biosimilar void requires coordinated action across an entire ecosystem of stakeholders – manufacturers, providers, payers, and policymakers. Learn more on what needs to change: https://accessiblemeds.org/resources/blog/2025-savings-report

12/17/2025

Book Your Access! 2026 Hotel Before Rates Go Up

The holiday season is around the corner, and rooms for Access! 2026 are filling fast. The discounted group rate ends December 20, and once it closes, higher rates and limited availability are likely.

brings together policymakers, influential speakers, and industry leaders to chart the future of generics and biosimilars. Staying at the conference hotel ensures you’re steps away from sessions, networking opportunities, and the full Access! experience.

Secure your spot before the year-end rush. 👉 Book now and lock in the best rate! https://access.accessiblemeds.org

12/15/2025

Brian Reid Brings Strategic Insight to Access! 2026

Join Brian Reid, Founder and Principal of Reid Strategic and Senior Fellow at Tufts’ Center for the Evaluation of Value and Risk in Health, for a fireside chat with Alex Keeton, Executive Director of the Biosimilars Council and AAM’s Senior VP of Policy.

Together, they’ll explore how generics and biosimilars can shape the conversation on value, access, and affordability—and how strategic storytelling can move the needle in Washington and beyond.

Don’t miss this must-see session at Access! 2026—
where insight meets impact. Register now: https://access.accessiblemeds.org

12/12/2025

DRUG SHORTAGES HAMPER PATIENT CARE! Continued drug shortages are a result of unsustainably low pricing, increases in government policies – including tariffs – that further compound market dynamics, and regulatory challenges. Learn more in the : https://accessiblemeds.org/resources/blog/2025-savings-report

12/08/2025

PBMs DELAY PATIENT SAVINGS! First generics, or medicines approved by FDA as the first competitor to the brand drug, often face challenges in market adoption. Slower adoption for first generics is driven in part by slower coverage decisions of PBMs and health plans. These entities benefit from rebates on high-priced brand drugs, even though patients would save through lower-cost generics and biosimilars. Learn more: https://accessiblemeds.org/resources/blog/2025-savings-report

12/05/2025

and provide critical savings throughout the U.S. healthcare system and are particularly valuable to Medicare and the patients they serve. In 2024, the use of generics saved $142 billion in Medicare and $62 billion in Medicaid. Learn more about savings from this essential industry and what can be done to ensure America’s patients can thrive with access to these lower-cost medications: : https://accessiblemeds.org/resources/blog/2025-savings-report

Address

601 New Jersey Avenue NW, Suite 850
Washington D.C., DC
20001

Telephone

+12022497100

Website

http://www.accessiblemeds.org/

Alerts

Be the first to know and let us send you an email when Association for Accessible Medicines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Association for Accessible Medicines:

Want your practice to be the top-listed Clinic in Washington D.C.?